SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-063690
Filing Date
2022-03-03
Accepted
2022-03-03 08:18:37
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 d292566ds3.htm S-3 764274
2 EX-4.5 d292566dex45.htm EX-4.5 275222
3 EX-4.6 d292566dex46.htm EX-4.6 284716
4 EX-5.1 d292566dex51.htm EX-5.1 116859
5 EX-5.2 d292566dex52.htm EX-5.2 62453
6 EX-5.3 d292566dex53.htm EX-5.3 16638
7 EX-23.1 d292566dex231.htm EX-23.1 1272
8 EX-FILING FEES d292566dexfilingfees.htm EX-FILING FEES 91957
9 GRAPHIC g292566dsp1.jpg GRAPHIC 5015
10 GRAPHIC g292566dsp1a.jpg GRAPHIC 2545
11 GRAPHIC g292566g0509114156154.jpg GRAPHIC 1464
12 GRAPHIC g292566g0509114156263.jpg GRAPHIC 2593
13 GRAPHIC g292566g30t61.jpg GRAPHIC 40415
  Complete submission text file 0001193125-22-063690.txt   1682778
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-263251 | Film No.: 22706809
SIC: 2834 Pharmaceutical Preparations